Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.7400
-0.0350 (-4.52%)
Apr 16, 2026, 4:10 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 93.47 million as of April 15, 2026. Its market cap has decreased by -29.91% in one year.
Market Cap
93.47M
Enterprise Value
94.59M
Revenue
32.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.74
Market Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 93.47M, an increase of 83.67%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 93.62M | -14.04% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 66.24B |
| Sigma Healthcare | 30.71B |
| Pro Medicus | 13.79B |
| Cochlear | 11.45B |
| Island Pharmaceuticals | 104.93M |
| Arovella Therapeutics | 102.61M |
| Paradigm Biopharmaceuticals | 99.39M |
| BlinkLab | 98.84M |